Susan Niles v. HHS - Influenza, Guillain-Barré syndrome (GBS) and/or chronic inflammatory demyelinating polyneuropathy (CIDP) (2024)
Case summary [AI summaries can sometimes make mistakes]
Susan Niles filed a petition for compensation on September 16, 2022, alleging that the influenza vaccine she received on October 7, 2019, caused her to develop Guillain-Barré syndrome (GBS) and/or chronic inflammatory demyelinating polyneuropathy (CIDP). She further alleged that she suffered residual effects for more than six months.
The influenza vaccine is listed on the Vaccine Injury Table. The respondent denied that the vaccine caused her condition or any other injury.
The parties reached a joint stipulation for settlement, which Special Master Christian J. Moran adopted as the decision of the Court.
Ms. Niles was awarded a lump sum of $145,000.00, payable by check to the petitioner, as compensation for all damages available under the program.
The clerk was directed to enter judgment according to this decision and the stipulation. Petitioner counsel was Robert P.
Goodwin of Walsh Roberts & Grace, and respondent counsel was Neil Bhargava of the United States Department of Justice. The decision was filed on March 14, 2024.
Theory of causation
Petitioner Susan Niles alleged that the influenza vaccine received on October 7, 2019, caused Guillain-Barré syndrome (GBS) and/or chronic inflammatory demyelinating polyneuropathy (CIDP), with residual effects lasting more than six months. The influenza vaccine is listed on the Vaccine Injury Table, and the condition is defined in the Table. Respondent denied causation. The parties reached a stipulation for settlement, which was adopted by Special Master Christian J. Moran. The stipulation resulted in a $145,000.00 lump sum award to the petitioner. The public decision does not describe the specific onset, symptoms, medical tests, treatments, or expert witnesses. The theory of causation relies on the Vaccine Injury Table. The decision was filed on March 14, 2024. Petitioner counsel was Robert P. Goodwin, and respondent counsel was Neil Bhargava.
Source PDFs
USCOURTS-cofc-1_22-vv-01316